<> <http://www.w3.org/2000/01/rdf-schema#comment> "The repository administrator has not yet configured an RDF license."^^<http://www.w3.org/2001/XMLSchema#string> .
<> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/60183> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/AcademicArticle> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Article> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/title> "CLINICAL DYNAMICS OF HEMOSTATIC SYSTEM PARAMETERS AND THE ROLE OF BIOMARKERS IN PATIENTS WITH IMMUNE MICROTHROMBOVASCULITIS UNDER ANTICOAGULANT THERAPY"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/ontology/bibo/abstract> "Immune microthrombovasculitis (IMTV) is a rare disorder characterized by immune-mediated microvascular thrombosis, often requiring anticoagulant therapy to mitigate thrombotic complications. This prospective study investigates the dynamics of hemostatic system parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and biomarkers (von Willebrand factor [vWF], C-reactive protein [CRP]) in 40 patients with IMTV over a 12-month period. Patients received either warfarin or direct oral anticoagulants (DOACs). Significant reductions in D-dimer levels (from 1.3 µg/mL to 0.5 µg/mL, p&lt;0.01) and stabilization of APTT were observed in 85% of DOAC-treated patients. Fibrinogen levels remained elevated in 55% of patients, correlating with CRP (r=0.68, p&lt;0.01). Elevated vWF levels at baseline (185 IU/dL) decreased modestly (145 IU/dL, p=0.04), reflecting partial endothelial recovery. Persistent vWF elevation was associated with a 20% incidence of recurrent thrombotic events. These findings underscore the utility of hemostatic parameters and biomarkers in monitoring therapy efficacy and predicting outcomes, advocating for personalized treatment strategies in IMTV."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/date> "2025-06-09" .
<https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Organization> .
<https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c> <http://xmlns.com/foaf/0.1/name> "Center for Tech and Media Research"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/publisher> <https://arxiv.universalpublishings.com/id/org/ext-20ef1f289b7920027328009b5eefe52c> .
<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/ontology/bibo/Collection> .
<https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36> <http://xmlns.com/foaf/0.1/name> "Multidisciplinary Journal of Science and Technology"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/publication/ext-d62a5dbdabc792c15cf76756361a4d36> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/ontology/bibo/status> <http://purl.org/ontology/bibo/status/published> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-8ec4ece4af26d73954b037234b569efc> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/60183#authors> .
<https://arxiv.universalpublishings.com/id/eprint/60183#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_1> <https://arxiv.universalpublishings.com/id/person/ext-8ec4ece4af26d73954b037234b569efc> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-3e3a5fca811d531c0bb513d6947db7a3> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/60183#authors> .
<https://arxiv.universalpublishings.com/id/eprint/60183#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_2> <https://arxiv.universalpublishings.com/id/person/ext-3e3a5fca811d531c0bb513d6947db7a3> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/creator> <https://arxiv.universalpublishings.com/id/person/ext-a095904c6566a0b3e59aaaf70d69941d> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/ontology/bibo/authorList> <https://arxiv.universalpublishings.com/id/eprint/60183#authors> .
<https://arxiv.universalpublishings.com/id/eprint/60183#authors> <http://www.w3.org/1999/02/22-rdf-syntax-ns#_3> <https://arxiv.universalpublishings.com/id/person/ext-a095904c6566a0b3e59aaaf70d69941d> .
<https://arxiv.universalpublishings.com/id/person/ext-3e3a5fca811d531c0bb513d6947db7a3> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-3e3a5fca811d531c0bb513d6947db7a3> <http://xmlns.com/foaf/0.1/givenName> "Sayfuddinova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-3e3a5fca811d531c0bb513d6947db7a3> <http://xmlns.com/foaf/0.1/familyName> "Z.A"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-3e3a5fca811d531c0bb513d6947db7a3> <http://xmlns.com/foaf/0.1/name> "Sayfuddinova Z.A"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-8ec4ece4af26d73954b037234b569efc> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-8ec4ece4af26d73954b037234b569efc> <http://xmlns.com/foaf/0.1/givenName> "Z.Ch."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-8ec4ece4af26d73954b037234b569efc> <http://xmlns.com/foaf/0.1/familyName> "Kurbanova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-8ec4ece4af26d73954b037234b569efc> <http://xmlns.com/foaf/0.1/name> "Z.Ch. Kurbanova"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-a095904c6566a0b3e59aaaf70d69941d> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://xmlns.com/foaf/0.1/Person> .
<https://arxiv.universalpublishings.com/id/person/ext-a095904c6566a0b3e59aaaf70d69941d> <http://xmlns.com/foaf/0.1/givenName> ".A."^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-a095904c6566a0b3e59aaaf70d69941d> <http://xmlns.com/foaf/0.1/familyName> "Begmatova3"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/person/ext-a095904c6566a0b3e59aaaf70d69941d> <http://xmlns.com/foaf/0.1/name> ".A. Begmatova3"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/EPrint> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://eprints.org/ontology/ArticleEPrint> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://purl.org/dc/terms/isPartOf> <https://arxiv.universalpublishings.com/id/repository> .
<https://arxiv.universalpublishings.com/id/eprint/60183> <http://www.w3.org/2000/01/rdf-schema#seeAlso> <https://arxiv.universalpublishings.com/id/eprint/60183/> .
<https://arxiv.universalpublishings.com/id/eprint/60183/> <http://purl.org/dc/elements/1.1/title> "HTML Summary of #60183 \n\nCLINICAL DYNAMICS OF HEMOSTATIC SYSTEM PARAMETERS AND THE ROLE OF BIOMARKERS IN PATIENTS WITH IMMUNE MICROTHROMBOVASCULITIS UNDER ANTICOAGULANT THERAPY\n\n" .
<https://arxiv.universalpublishings.com/id/eprint/60183/> <http://purl.org/dc/elements/1.1/format> "text/html" .
<https://arxiv.universalpublishings.com/id/eprint/60183/> <http://xmlns.com/foaf/0.1/primaryTopic> <https://arxiv.universalpublishings.com/id/eprint/60183> .